Digital Look

Welcome to Digital Look++,
you are not logged in

e-Therapeutics (ETX)

Pharma and Biotech

9.40p

Trade now with Barclays Stockbrokers

Select chart: EPS | Dividend | Revenue

Period Ending	Period	Revenue (£m)	Pre-tax (£m)	EPS	Dividend
31-Jul-23	Interim	0.16	(6.63)	(0.97)p	n/a

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Jan-19	0.04	(5.09)	(1.49)p	n/a	n/a	n/a	n/a	0.0%
31-Jan-20	0.46	(2.87)	(0.87)p	n/a	n/a	n/a	n/a	0.0%
31-Jan-21	0.32	(4.47)	(0.99)p	n/a	n/a	n/a	n/a	0.0%
31-Jan-22	0.48	(9.52)	(1.65)p	n/a	n/a	n/a	n/a	0.0%
31-Jan-23	0.47	(9.77)	(1.54)p	n/a	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts data is not available for this company.

	5 Yr High	5 Yr Low	5 Yr Avg	Curr / Avg
Latest	n/a	n/a	n/a	0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

Find out about IFRS and how this affects the financial infomation for all UK companies.